The Claimed Intermediate Online Database and Reports cover Process Patents for Marketed Pharmaceutical Drugs and the Intermediates used therein.

• Unique Online Database allows Intermediate/API/INN text and structure searching
• Includes API/INNs in at least one major Market
• Locates Drug Synthesis often buried in a Plethora of Patents
• Provides targeted Patent data in a Visual form
• Drug syntheses obtained by analysing Patent documents

• Subscription-based, no additional hit costs
• Save on patent searching/analysis
• Only new applications, no repeated equivalents
• Reduce manpower cost
• Informs Commercial Synthesis profitability

• 700+ Drugs • 3000+ Patents • 17,600+ Structures • 3600+ Records with 1000+ Claimed Intermediates • nearly 1000 Patentees including Joint Patentees &c

Top Database Records:

Atorvastatin, Dronedarone, Sitagliptin, Rosuvastatin, Rivaroxaban, Aliskiren, Iodixanol, Lacosamide, Paliperidone, Pregabalin, Tapentadol, Agomelatine, Febuxostat, Fesoterodine, Ivabradine, Ticagrelor, Cinacalcet, Montelukast, Bosentan, Esomeprazole, Imatinib, Sunitinib, Prasugrel, Darunavir, Duloxetine, Ezetimibe, Asenapine, Dabigatran etexilate, Linezolid, Olmesartan Medoxomil, Pitavastatin, Bendamustine, Efavirenz, Telaprevir, Telmisartan, Tiotropium bromide, Caspofungin, Desvenlafaxine, Bimatoprost, Drospirenone, Ertapenem, Etoricoxib, Meropenem, Ramelteon, Rasagiline, Saxagliptin, Silodosin, Vilazodone, Ambrisentan, Azilsartan medoxomil



Try the Free Quarterly Report in the Shop.

What is a Claimed Intermediate?
A Claimed Intermediate is here defined as a novel pharmaceutical process intermediate which is preferably highly stable, highly isolatable, highly purifiable (optionally with appropriate chirality) and claimed as a compound in a pharmaceutical process patent specification from which it may be subject to a 20 year patent protection term.